Latest Advances

  • Condition: Frontotemporal Dementia (FTD)
  • Journal: BMJ case reports
  • Treatment Used: Routinizing Therapy
  • Number of Patients: 1
  • Published —
This case report examined whether Instrumental Activities of Daily Living (IADL) improves with routinizing therapy for a patient with frontotemporal dementia (FTD) living in a group home.
  • Condition: Frontotemporal Dementia
  • Journal: Journal of Alzheimer's disease : JAD
  • Treatment Used: Palmitoylethanolamide with Luteoline
  • Number of Patients: 17
  • Published —
The study researched the safety and effectiveness of palmitoylethanolamide combined with luteoline for treating frontotemporal dementia.
  • Condition: Alzheimer's disease
  • Journal: Journal of Alzheimer's disease : JAD
  • Treatment Used: Omega-3 Fatty Acid Drink Smartfish
  • Number of Patients: 28
  • Published —
In this study, researchers evaluated the outcomes of adding the omega-3 fatty acid drink Smartfish to conventional treatment in persons with Alzheimer's disease.
  • Condition: Catatonia in Frontotemporal Dementia
  • Journal: Clinical neuropharmacology
  • Treatment Used: Zolpidem
  • Number of Patients: 1
  • Published —
This study evaluated the effectiveness of zolpidem in patients with catatonia (disorder involving the connection between mental function and movement) in frontotemporal dementia (type of dementia that happens because of damage to the frontal and temporal lobes of the brain).
  • Condition: Amyotrophic Lateral Sclerosis (ALS)
  • Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration
  • Treatment Used: Triumeq
  • Number of Patients: 40
  • Published —
This study evaluated the safety and tolerability of Triumeq in patients with amyotrophic lateral sclerosis (progressive nervous system disease that affects nerve cells in the brain and spinal cord, causing loss of muscle control; ALS).
  • Condition: Amyotrophic Lateral Sclerosis (ALS)
  • Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration
  • Treatment Used: Masitinib as Add-On Therapy to Riluzole
  • Number of Patients: 394
  • Published —
This study assessed masitinib in the treatment of amyotrophic lateral sclerosis (ALS).
  • Condition: Non-Alzheimer's Dementias
  • Journal: Drugs & aging
  • Treatment Used: Cholinesterase Inhibitors
  • Number of Patients: 0
  • Published —
The study researched the effects of cholinesterase inhibitors for non-alzheimer's dementias.
  • Condition: Alzheimer's Disease
  • Journal: Brain : a journal of neurology
  • Treatment Used: Amyloid-? Immunization
  • Number of Patients: 22
  • Published —
This study performed a 15-year post-mortem neuropathological follow-up of patients in the first trial of amyloid-? immunotherapy for Alzheimer's disease.
  • Condition: Dementia (Alzheimer's Disease)
  • Journal: The Cochrane database of systematic reviews
  • Treatment Used: Memantine
  • Number of Patients: 10000
  • Published —
This review of the literature determined the effectiveness and safety of memantine for people with dementia, and assessed whether memantine adds benefit for people already taking cholinesterase inhibitors (ChEIs).
  • Condition: Alzheimer's Dementia
  • Journal: Deutsche medizinische Wochenschrift (1946)
  • Treatment Used: Antidementia Drug Therapy
  • Number of Patients: 0
  • Published —
This article discusses anti-dementia drug therapy of Alzheimer's dementia.
  • Condition: Amyotrophic lateral sclerosis
  • Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration
  • Treatment Used: EH301
  • Number of Patients: 32
  • Published —
The study researched the safety and effectiveness of EH301 in treating amyotrophic lateral sclerosis.
  • Condition: Lou Gehrig's disease
  • Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration
  • Treatment Used: Lunasin
  • Number of Patients: 50
  • Published —
The study researched the effects of Lunasin on Lou Gehrig's disease.
Showing 1-12 of 17